A team led by UNSW Sydney researchers is investigating ways through e-health to increase access to much-needed treatment for fear of cancer recurrence...
More and more children are surviving leukaemia and brain cancer, but many are left with longer-term communication problems. Dr Kimberley Docking has...
UNSW Sydney and the Garvan Institute of Medical Research researchers will lead the program, thanks to a $3.75 million grant from the Cancer Institute...
Date Time
Pancreatic cancer clinical trial program to target genome an
Garvan and UNSW Sydney researchers will establish and lead an innovative pancreatic cancer clinical trial program, thanks to a $3.75 million grant from the Cancer Institute NSW.
A national clinical trial program will test promising new targeted therapy for pancreatic cancer, one of the deadliest forms of cancers of which more than 3000 cases are diagnosed annually in Australia alone.
The clinical trial program (MoST-P), led by researchers and clinicians at UNSW Sydney and the Garvan Institute of Medical Research, will provide patients with access to either targeted therapies matched to the genomic signature of their individual tumour, or targeted to the tumour environment.